(Q33963376)

30 July 2017

1 reference

title

The clinical relevance of the anti-inflammatory properties of antihistamines (English)

1 reference

30 July 2017

1 reference

Walsh GM

1

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

55 Suppl 60

1 reference

30 July 2017

page(s)

53-61

1 reference

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

T cells and eosinophils in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

TH1 and TH2 CD4+ cells in human allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Human eosinophils: their accumulation, activation and fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Eosinophilic Inflammation in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Skin eosinophilia in atopic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Cytokine generation by eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

The effects of cetirizine on the function of inflammatory cells involved in the allergic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Leukotriene B4 production by blood neutrophils in allergic rhinitis—effects of cetirizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

A study of the Interaction Between Cetirizine and Plasma Membrane of Eosinophils, Neutrophils, Platelets and Lymphocytes using A fluorescence Technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

The bronchial epithelium as a target for inflammatory attack in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Protective effect of different doses of terfenadine on the conjunctival provocation test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Mucosal inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Viruses as precipitants of asthma symptoms. I. Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Upper airway inflammatory diseases and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

21 January 2018

Antihistamines in asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Spontaneous histamine release and histamine content in normal subjects and subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Effect of cetirizine, a new H1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Prophylactic treatment of grass pollen-induced asthma with cetirizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Terfenadine, a potent histamine H1-receptor antagonist in the treatment of grass pollen sensitive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Treatment of bronchial asthma with terfenadine; a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

21 January 2018

G-proteins in allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Effects of Cetirizine on Human Eosinophil and Neutrophil Activation in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Antihistamines in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

The comparative actions and adverse effect profile of single doses of H1-receptor antihistamines in the airways and skin of subjects with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Dose-response relationship of the H1-histamine antagonist, ebastine, against histamine and methacholine-induced bronchoconstriction in patients with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Effect of cetirizine, a potent H1 antagonist, on platelet activating factor induced bronchoconstriction in asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Effect of oral and inhaled cetirizine in allergen induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

The effect of azelastine on the infiltration of inflammatory cells into the bronchial mucosa and clinical changes in patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Corticosteroid-sparing effect of azelastine in the management of bronchial asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Duration of action of a single dose of azelastine in patients with chronic asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Is there a place for antihistamines in the treatment of perennial asthma?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Effect of a non-sedative antihistaminic (loratadine) in moderate asthma. A double-blind controlled clinical crossover-trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00009.X

7 January 2021

10.1034/J.1398-9995.2000.00009.X

Identifiers

DOI

1 reference

30 July 2017

1 reference